Insider Transactions in Q1 2023 at Pyxis Oncology, Inc. (PYXS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2023
|
Freda C Lewis Hall |
BUY
Grant, award, or other acquisition
|
Direct |
139,355
+40.33%
|
-
|
|
Mar 24
2023
|
Jitendra Wadhane SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
74,393
+26.8%
|
-
|
|
Mar 24
2023
|
Jay Feingold Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
209,803
+22.32%
|
-
|
|
Mar 24
2023
|
Connealy Pamela Yanchik CFO & COO |
BUY
Grant, award, or other acquisition
|
Direct |
209,803
+26.09%
|
-
|
|
Mar 24
2023
|
Lara Sullivan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
703,379
+24.6%
|
-
|
|
Mar 24
2023
|
Thomas Civik |
BUY
Grant, award, or other acquisition
|
Direct |
139,355
+40.33%
|
-
|
|
Mar 24
2023
|
Darren S Cline |
BUY
Grant, award, or other acquisition
|
Direct |
139,355
+39.2%
|
-
|
|
Mar 24
2023
|
John L Flavin |
BUY
Grant, award, or other acquisition
|
Direct |
139,355
+26.95%
|
-
|
|
Mar 24
2023
|
Rachel Humphrey |
BUY
Grant, award, or other acquisition
|
Direct |
58,064
+50.0%
|
-
|
|
Mar 17
2023
|
Pfizer Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,811,594
+23.33%
|
$3,623,188
$2.76 P/Share
|
|
Jan 03
2023
|
Connealy Pamela Yanchik CFO & COO |
BUY
Grant, award, or other acquisition
|
Direct |
43,493
+10.16%
|
-
|
|
Jan 03
2023
|
Jay Feingold Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,931
+9.39%
|
-
|
|
Jan 03
2023
|
Lara Sullivan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
95,684
+6.18%
|
-
|